-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AHKNedrUPcn1KKu9Tl4QWCBcJLfSsbP6VtBRgsiEpovcHYj+8v2lTryilIYGf6qd hR2SOlokeqiD+BnfwzqPnA== 0001047469-03-003130.txt : 20030129 0001047469-03-003130.hdr.sgml : 20030129 20030129165155 ACCESSION NUMBER: 0001047469-03-003130 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20030129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REGEN BIOLOGICS INC CENTRAL INDEX KEY: 0000883697 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232476415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49089 FILM NUMBER: 03530286 BUSINESS ADDRESS: STREET 1: 1650 TYSONS BLVD CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 7038471400 MAIL ADDRESS: STREET 1: 1650 TYSONS BLVD CITY: MCLEAN STATE: VA ZIP: 22102 FORMER COMPANY: FORMER CONFORMED NAME: APACHE MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19960426 FORMER COMPANY: FORMER CONFORMED NAME: AROS CORP DATE OF NAME CHANGE: 20010712 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EDWARDS LIFESCIENCES CORP CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 17221 RED HILL AVE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: 17221 RED HILL AVE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 SC 13G/A 1 a2101662zsc13ga.htm SC 13G/A
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1—Final Amendment)

OMB APPROVAL

OMB Number: 3235-0145

Expires: December 31, 2005

Estimated average burden
hours per response. . . 11

REGEN BIOLOGICS, INC.

(Name of Issuer)
Common Stock, par value $0.01 per share

(Title of Class of Securities)
		04268Q-101
		(CUSIP Number)
June 21, 2002

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

ý Rule 13d-1(c)

o Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 4268Q-101 Schedule 13G Page 2 of 5


1.	NAME OF REPORTING PERSON Edwards Lifesciences LLC I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 36-4345053 NAME OF REPORTING PERSON Edwards Lifesciences Corporation I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 36-4316614


2.	CHECK THE APPROPRIATE BOX IF A	(a)	o
	MEMBER OF A GROUP	(b)	o


3.	SEC USE ONLY


4.	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5.	SOLE VOTING POWER
			0

		6.	SHARED VOTING POWER
			573,346

		7.	SOLE DISPOSITIVE POWER
			0

		8.	SHARED DISPOSITIVE POWER
			573,346

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	573,346

10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
	Not Applicable.

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	3.4%

12.	TYPE OF REPORTING PERSON
	Edwards Lifesciences LLC: OO Edwards Lifesciences Corporation: CO

CUSIP No. 4268Q-101 Schedule 13G Page 3 of 5

This Statement constitutes final Amendment No. 1 to the Schedule 13G of Edwards Lifesciences LLC, a Delaware limited liability company ("Edwards"), and Edwards Lifesciences Corporation, a Delaware corporation and owner of 100% of the equity interests of Edwards.

Item 1.

(a)		NAME OF ISSUER
		ReGen Biologics, Inc. (the "Company")

(b)		ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
		1290 Bay Dale Drive, PMB 351, Arnold, Maryland 21012

Item 2.

(a)		NAME OF PERSONS FILING
		Edwards Lifesciences LLC, a Delaware limited liability company ("Edwards"), and Edwards Lifesciences Corporation, a Delaware corporation and owner of 100% of the equity interests of Edwards.

(b)		ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
		One Edwards Way Irvine, California 92614

(c)		CITIZENSHIP
		Delaware

(d)		TITLE OF CLASS OF SECURITIES
		Common Stock, par value $1.00 per share, of the Company ("Common Stock")

(e)		CUSIP NO:
		04268Q-101

Item 3.

If this statement is filed pursuant to Rule 13d-1(c), check this box. ý

CUSIP No. 4268Q-101 Schedule 13G Page 4 of 5

Item 4. OWNERSHIP

(a)	Amount Beneficially Owned:
		573,346 shares of Common Stock

(b)	Percent of Class:
		3.4% (based on 17,045,131 shares of Common Stock outstanding as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)

(c)	Number of shares as to which the person has:

	(i)	sole power to vote or to direct the vote:
		0

	(ii)	shared power to vote or to direct the vote:

		573,346

	(iii)	sole power to dispose or to direct the disposition of:
		0

	(iv)	shared power to dispose or to direct the disposition of:
		573,346

Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ý

Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable.

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

Not applicable.

Item 9. NOTICE OF DISSOLUTION OF GROUP

Not applicable.

Item 10. CERTIFICATIONS

Not applicable.

CUSIP No. 4268Q-101 Schedule 13G Page 5 of 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: January 29, 2003

		EDWARDS LIFESCIENCES LLC
		/s/ JAY P. WERTHEIM
		By:		Jay P. Wertheim
		Title:		Vice President, Associate General Counsel



		EDWARDS LIFESCIENCES CORPORATION
		/s/ JOHN H. KEHL, JR.
		By:		John H. Kehl, Jr.
		Title:		Corporate Vice President, Strategy and Business Development

Exhibit Index

Exhibit 1

Agreement of Joint Filing

Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

Item 9. NOTICE OF DISSOLUTION OF GROUP

Item 10. CERTIFICATIONS

SIGNATURE
Exhibit Index
EX-1 3 a2101662zex-1.htm EXHIBIT 1
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 1

Agreement of Joint Filing

Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, the undersigned agree that the statement to which this exhibit is attached is filed on behalf of each of them in the capacities set forth below.

Date: January 29, 2003

		EDWARDS LIFESCIENCES LLC
		/s/ JAY P. WERTHEIM
		By:		Jay P. Wertheim
		Title:		Vice President, Associate General Counsel



		EDWARDS LIFESCIENCES CORPORATION
		/s/ JOHN H. KEHL, JR.
		By:		John H. Kehl, Jr.
		Title:		Corporate Vice President, Strategy and Business Development

QuickLinks

Exhibit 1

Agreement of Joint Filing
-----END PRIVACY-ENHANCED MESSAGE-----